Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05013944 · ClinicalTrials.gov registry record
AnovaOS Network Powered Patient Registry
A clinical trial of Neoplasms and Infectious Disease, sponsored by Anova Enterprises.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 1
- Study location
NCT05013944 is a study of Neoplasms and Infectious Disease that is actively recruiting participants, run by Anova Enterprises. The registered enrollment target is 100,000 participants, above the 988-participant average among 158 other Neoplasms trials with a reported enrollment target (10021% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05013944, a study of Neoplasms and Infectious Disease, is actively recruiting participants, sponsored by Anova Enterprises.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.
Conditions Studied
Study Locations (1)
Illinois
- Anova Enterprises, Inc. - Arlington Heights
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2026-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05013944
The ClinicalTrials.gov registry entry for NCT05013944 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 988-participant average among 158 other Neoplasms trials with a reported enrollment target (10021% higher). The listed sponsor is Anova Enterprises, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT05013944 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05013944 about?
NCT05013944 is a clinical study titled "AnovaOS Network Powered Patient Registry". The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.
What is the current status of trial NCT05013944?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2021-09-01. Estimated completion is 2026-08-31.
What conditions does trial NCT05013944 study?
This clinical trial studies the following conditions: Neoplasms, Infectious Disease, Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89), Endocrine, Nutritional and Metabolic Diseases (E00-E89), Mental and Behavioural Disorders.
Who is sponsoring clinical trial NCT05013944?
This trial is sponsored by Anova Enterprises, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05013944 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
RECRUITING · Phase 1
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)
RECRUITING · Phase 1
-
Endometrial Cell Collection With the PadKit
RECRUITING · NA
-
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
RECRUITING · Phase 1
-
Resilience in East Asian Immigrants for Advance Care Planning Discussions
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.